Literature DB >> 16407210

Single amino acid substitution in the PC1/3 propeptide can induce significant modifications of its inhibitory profile toward its cognate enzyme.

Nadia Rabah1, Dany Gauthier, Brian C Wilkes, Daniel J Gauthier, Claude Lazure.   

Abstract

The proprotein convertase PC1/3 is synthesized as a large precursor that undergoes proteolytic processing of the signal peptide, the propeptide and ultimately the COOH-terminal tail, to generate the mature form. The propeptide is essential for protease folding, and, although cleaved by an autocatalytic process, it remains associated with the mature form acting as an auto-inhibitor of PC1/3. To further assess the role of certain residues in its interaction with its cognate enzyme, we performed an alanine scan on two PC1/3 propeptide potential cleavable sites ((50)RRSRR(54) and (61)KR(62)) and an acidic region (65)DDD(67) conserved among species. Upon incubation with PC1/3, the ensuing peptides exhibit equal inhibitory potency, lower potency, or higher potency than the wild-type propeptide. The K(i) values calculated varied between 0.15 and 16.5 nm. All but one mutant exhibited a tight binding behavior. To examine the specificity of mutants, we studied their reactivity toward furin, a closely related convertase. The mutation of certain residues also affects the inhibition behavior toward furin yielding propeptides exhibiting K(i) ranging from 0.2 to 24 nm. Mutant propeptides exhibited against each enzyme either different mode of inhibition, enhanced selectivity in the order of 40-fold for one enzyme, or high potency with no discrimination. Hence, we demonstrate through single amino acid substitution that it is feasible to modify the inhibitory behavior of propeptides toward convertases in such a way as to increase or decrease their potency, modify their inhibitory mechanisms, as well as increase their selectivity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16407210     DOI: 10.1074/jbc.M510607200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

Review 1.  Proteases for processing proneuropeptides into peptide neurotransmitters and hormones.

Authors:  Vivian Hook; Lydiane Funkelstein; Douglas Lu; Steven Bark; Jill Wegrzyn; Shin-Rong Hwang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

2.  A novel enediynyl peptide inhibitor of furin that blocks processing of proPDGF-A, B and proVEGF-C.

Authors:  Ajoy Basak; Abdel-Majid Khatib; Dayani Mohottalage; Sarmistha Basak; Maria Kolajova; Subhendu Sekhar Bag; Amit Basak
Journal:  PLoS One       Date:  2009-11-26       Impact factor: 3.240

3.  A nonsense loss-of-function mutation in PCSK1 contributes to dominantly inherited human obesity.

Authors:  J Philippe; P Stijnen; D Meyre; F De Graeve; D Thuillier; J Delplanque; G Gyapay; O Sand; J W Creemers; P Froguel; A Bonnefond
Journal:  Int J Obes (Lond)       Date:  2014-06-03       Impact factor: 5.095

4.  Functional consequences of a novel variant of PCSK1.

Authors:  Lindsay A Pickett; Michael Yourshaw; Valeria Albornoz; Zijun Chen; R Sergio Solorzano-Vargas; Stanley F Nelson; Martín G Martín; Iris Lindberg
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

5.  A novel mutation in the mouse Pcsk1 gene showing obesity and diabetes.

Authors:  Nor I A Muhsin; Liz Bentley; Ying Bai; Michelle Goldsworthy; Roger D Cox
Journal:  Mamm Genome       Date:  2020-01-23       Impact factor: 2.957

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.